Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Cross-Species Hydroquinone Model Replicates Smoking-Related Corneal Endothelial Oxidative Injury and Enables Therapeutic Screening of FGF10. | Invest Ophthalmol Vis Sci | 2026 | 41789845 | PubTator, text mining | PubMed |
| Statin-Mediated Modulation of Nrf2 Signaling: Mechanisms and Therapeutic Implications in Atherosclerosis. | Rev Cardiovasc Med | 2026 | 41789331 | PubTator, text mining | PubMed |
| Targeting regulated cell death pathways in lung cancer: mechanisms, therapeutic strategies, and clinical translation. | Front Immunol | 2026 | 41789093 | PubTator, text mining | PubMed |
| The macrophage opera: from metabolic prolog to oncogenic crescendo in metabolic dysfunction-associated steatotic liver disease. | Front Med (Lausanne) | 2026 | 41788707 | PubTator, text mining | PubMed |
| MVP Inhibits Influenza A Virus-Induced Ferroptosis by Targeting IRF1 and Increasing FSP1 Activity. | Adv Sci (Weinh) | 2026 | 41782382 | PubTator, text mining | PubMed |
| Harnessing lipid-driven immunometabolic pathways in omental metastases to enhance immunotherapy in patients with ovarian cancer. | Signal Transduct Target Ther | 2026 | 41775684 | PubTator, text mining | PubMed |
| SynMicrobe-driven lignocellulose humification: Key enzymes, metabolic pathways, and two-stage degradation-reconstruction mechanisms revealed via metaproteomics. | J Biotechnol | 2026 | 41771323 | PubTator, text mining | PubMed |
| Ferroptosis and cuproptosis in head and neck squamous cell carcinoma: interconnected mechanisms and therapeutic implications. | Front Pharmacol | 2026 | 41769686 | PubTator, text mining | PubMed |
| Altered transposon element-derived genes distort oxygen-free radical scavenger systems in FXD. | NAR Mol Med | 2026 | 41768973 | PubTator, text mining | PubMed |
| Allele-specific splicing modulates protein isoforms and Alzheimer's risk. | bioRxiv | 2026 | 41756969 | PubTator, text mining | PubMed |
| Beyond Folding Enzymes: A Redox-Active "Solid Chaperone" Unlocks Recyclable, HPLC-Free Oxidative Protein Folding. | JACS Au | 2026 | 41755826 | PubTator, text mining | PubMed |
| Selenium-Thioredoxin Axis Contributes to Ferroptosis Resistance in Pancreatic Cancer Cells. | Int J Mol Sci | 2026 | 41752199 | PubTator, text mining | PubMed |
| Region-Specific NRF2 Signaling in HIV-Associated Neurocognitive Disorders: A Transcriptomic and Computational Histology Study. | Genes (Basel) | 2026 | 41751579 | PubTator, text mining | PubMed |
| In Vitro Investigations on the Antioxidant Effects of Vitamin D in a Panel of Cancer Cell Lines. | Biomedicines | 2026 | 41751370 | PubTator, text mining | PubMed |
| Dietary Lycopene Mitigates Reproductive Impairment in Heat-Stressed Rongchang Boars: Roles of Antioxidant, Anti-Inflammatory and Nrf2 Pathway. | Antioxidants (Basel) | 2026 | 41750625 | PubTator, text mining | PubMed |
| Inducing Ferroptosis: Sensitization Strategy for Radiotherapy and Its Application. | Antioxidants (Basel) | 2026 | 41750617 | PubTator, text mining | PubMed |
| Moonlighting Functions of Mammalian Peroxiredoxins in Cellular Signaling. | Antioxidants (Basel) | 2026 | 41750610 | PubTator, text mining | PubMed |
| NRF2-Targeted Therapy in Cardiovascular Disease Transitions from Systemic Activation to Precision Redox Medicine. | Antioxidants (Basel) | 2026 | 41750600 | PubTator, text mining | PubMed |
| Targeting Fatty Acids in Liver Cancer: Molecular Insights and Drug Approaches. | Biomolecules | 2026 | 41750397 | PubTator, text mining | PubMed |
| Selenoprotein thioredoxin reductase 1 promotes cancer cells ferroptosis by suppressing GPX4 expression. | Cell Death Differ | 2026 | 41748901 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=6